Physiologically Based Pharmacokinetic Model to Assess the Drug-Drug-Gene Interaction Potential of Belzutifan in Combination With Cyclin-Dependent Kinase 4/6 Inhibitors A total of 14,177 patients were ...
Donafenib plus TACE with or without PD-(L)1 inhibitors for the treatment of unresectable hepatocellular carcinoma: A multi-center retrospective study. This is an ASCO Meeting Abstract from the 2025 ...
Emerging from stealth, the company is debuting NEXUS, a Large Tabular Model (LTM) designed to treat business data not as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results